GoodRx (GDRX) Stock Price
$4.55 0%
to add to portfolio
AI Score

-
Alternative
2 -
Fundamental
4 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on GoodRx, AI stock picks, stock alerts and much more.
GDRX AI Stock Analysis
AI stock analysis for GDRX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like GoodRx (GDRX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
GoodRx (GDRX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of GoodRx (GDRX), currently trading at $4.55, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About GDRX

-
GoodRx Holdings, Inc.
-
Symbol
GDRX
-
Market
NASDAQ
-
Industry
Medical - Healthcare Information Services
-
Market Cap
1.7B
Similar Stocks
![]() |
GE HealthCare GEHC |
$82.46 0.9% |
5 |
![]() |
Schrodinger SDGR |
$21.45 5.7% |
5 |
![]() |
Spok SPOK |
$16.18 1.3% |
4 |
![]() |
Health Catalyst HCAT |
$4.47 0.2% |
3 |
![]() |
Progyny PGNY |
$21.49 2.5% |
7 |
News
GDRX Alternative Data
Web Traffic
GoodRx receives an estimated 21.5M monthly visitors to goodrx.com.
-
Web Traffic
21523790
-
Change from Previous Month
13.5%
-
3 Month Change
8.2%
-
YoY Change
8.2%
News Mentions
GoodRx was mentioned 3 times in the news yesterday.
-
News Mentions
3
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
25%
Reddit Mentions
GoodRx has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
Twitter Followers
GoodRx has 13,429 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.8% over the last month.
-
Twitter Followers
13429
-
Daily Change
0.1%
-
1 Month Change
0.8%
-
3 Month Change
0.2%
-
YoY Change
0.2%
Facebook Engagement
GoodRx has engaged 17,503 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
17503
-
Daily Change
4.2%
-
1 Month Change
32.4%
-
3 Month Change
57.5%
-
YoY Change
57.5%
Instagram Followers
GoodRx has 55,353 Instagram Followers on its main Instagram account, up by 0.4% over the last month.
-
Instagram Followers
55353
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
0.5%
-
YoY Change
0.5%
Youtube Subscribers
GoodRx has 24,400 subscribers on its main Youtube channel, up by 3% over the last month.
-
Youtube Subscribers
24400
-
Daily Change
0%
-
1 Month Change
3%
-
3 Month Change
10.4%
-
YoY Change
10.4%
App Downloads
-
App Downloads
160688
-
Daily Change
2.3%
-
1 Month Change
55.9%
-
3 Month Change
32.2%
-
YoY Change
32.2%
Job Postings
GoodRx has an estimated 31 open job postings, which is down -35.4% over the last month.
-
Job Postings
31
-
Daily Change
13.9%
-
1 Month Change
35.4%
-
3 Month Change
210%
-
YoY Change
210%
LinkedIn Employees
According to LinkedIn, GoodRx has 1,124 employees, down by -0.5% over the last month.
-
LinkedIn Employees
1124
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
0.9%
-
YoY Change
0.9%
Business Outlook
According to employee reviews, the business outlook among employees at GoodRx is 49 out of 100 (neutral).
-
Business Outlook
49
-
Change from Previous Month
2%
-
3 Month Change
0%
-
YoY Change
0%
GDRX Financials
GDRX Key Metrics
-
Total Revenue
$198.6M
-
Net Income
$16.1M
-
Earnings per Share
$0.0421
-
Free cash flow
$0
-
EBITDA
$19.1M
-
EBITDA Ratio
0.0964181
-
Total Assets
$1.4B
GDRX 2-year Revenue & Income
GDRX 2-year Free Cash Flow
GDRX Technicals
GDRX SMA
GDRX RSI
FAQ
What's the current price of GoodRx (GDRX) Stock?
The price of an GoodRx (GDRX) share is $4.55.
What's the market cap of GoodRx?
The current market cap of GoodRx is 1.7B.
Should I buy or sell GDRX?
GoodRx exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is GoodRx a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in GoodRx stock. There are several bearish signals and market challenges that could negatively impact GoodRx's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy GoodRx (GDRX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy GoodRx stock right now, as the outlook appears bearish.
What are some stocks similar to GoodRx (GDRX) that investors often compare it to?
GoodRx (GDRX) is often compared to similar stocks such as GE HealthCare, Schrodinger, Spok, Health Catalyst and Progyny.
What is the forecast for GoodRx's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast GoodRx's stock price to be around $4.16 in 2026. Starting from the current price of $4.55, this represents a 8.5% change in price, indicating a bearish outlook for the stock.
How to buy GoodRx (GDRX) Stock?
GoodRx stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy GoodRx shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.